Lakefront Biotherapeutics | GLPG - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
argenx SE USD 1.24B 213M 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Biogen USD 2.32B 663.6M 2026-09
Genmab DKK 748M 77M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.65B 101M 2026-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 5.64B 4.67B 2026-09
Merck EUR 4.34B 249M 2026-06
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Novartis USD 9.88B 325M 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
UCB EUR 2.96B 196M 2025-12
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09